Noliterax 10+2,5 mg filmovertrukne tabletter Dinamarca - dinamarquês - Lægemiddelstyrelsen (Danish Medicines Agency)

noliterax 10+2,5 mg filmovertrukne tabletter

les laboratoires servier - indapamid (vandfri), perindoprilarginin - filmovertrukne tabletter - 10+2,5 mg

Paraterax 8+2,5 mg tabletter Dinamarca - dinamarquês - Lægemiddelstyrelsen (Danish Medicines Agency)

paraterax 8+2,5 mg tabletter

les laboratoires servier - indapamid (vandfri), perindopril tert-butylamin - tabletter - 8+2,5 mg

Viacoram 3,5+2,5 mg tabletter Dinamarca - dinamarquês - Lægemiddelstyrelsen (Danish Medicines Agency)

viacoram 3,5+2,5 mg tabletter

les laboratoires servier - amlodipin, perindoprilarginin - tabletter - 3,5+2,5 mg

Valdoxan União Europeia - dinamarquês - EMA (European Medicines Agency)

valdoxan

les laboratoires servier - agomelatin - depressiv lidelse, major

Thymanax União Europeia - dinamarquês - EMA (European Medicines Agency)

thymanax

les laboratoires servier - agomelatin - depressiv lidelse, major

Libroxar 2+0,5 mg resoribletter, sublinguale Dinamarca - dinamarquês - Lægemiddelstyrelsen (Danish Medicines Agency)

libroxar 2+0,5 mg resoribletter, sublinguale

laboratoires smb s.a. - buprenorphinhydrochlorid, naloxonhydrochloriddihydrat - resoribletter, sublinguale - 2+0,5 mg

Libroxar 8+2 mg resoribletter, sublinguale Dinamarca - dinamarquês - Lægemiddelstyrelsen (Danish Medicines Agency)

libroxar 8+2 mg resoribletter, sublinguale

laboratoires smb s.a. - buprenorphinhydrochlorid, naloxonhydrochloriddihydrat - resoribletter, sublinguale - 8+2 mg

Tibsovo União Europeia - dinamarquês - EMA (European Medicines Agency)

tibsovo

les laboratoires servier - ivosidenib - leukemia, myeloid, acute; cholangiocarcinoma - antineoplastiske midler - tibsovo in combination with azacitidine is indicated for the treatment of adult patients with newly diagnosed acute myeloid leukaemia (aml) with an isocitrate dehydrogenase-1 (idh1) r132 mutation who are not eligible to receive standard induction chemotherapy (see section 5. tibsovo monotherapy is indicated for the treatment of adult patients with locally advanced or metastatic cholangiocarcinoma with an idh1 r132 mutation who were previously treated by at least one prior line of systemic therapy.

Monoprost 50 mikrogram/ml øjendråber, opløsning, enkeltdosisbeholder Dinamarca - dinamarquês - Lægemiddelstyrelsen (Danish Medicines Agency)

monoprost 50 mikrogram/ml øjendråber, opløsning, enkeltdosisbeholder

paranova danmark a/s - latanoprost - øjendråber, opløsning, enkeltdosisbeholder - 50 mikrogram/ml